AEMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aethlon Medical Inc (AEMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial growth, absence of significant trading trends, and no recent positive news or catalysts make it a less compelling investment opportunity. Additionally, technical indicators are neutral, and there are no strong proprietary trading signals to suggest immediate action.
The MACD histogram is positive but contracting, suggesting weakening momentum. RSI is neutral at 61.935, and moving averages are converging, indicating no clear trend. Key support and resistance levels show the stock is trading near its pivot point, with resistance at 2.391 and support at 2.128.
NULL identified. No recent news or significant trading trends from hedge funds or insiders. MACD is slightly positive, but the signal is weak.
is also down (-1.79%), which may indicate a bearish sentiment overall.
In Q3 2026, the company reported no revenue growth (0% YoY) and a net income loss of -$2,018,245, despite a 15.01% YoY improvement. EPS dropped significantly by -75.62% YoY, indicating poor profitability trends.
No analyst rating or price target changes available. Wall Street sentiment is neutral with no strong pros or cons.
